Immediate Impact
1 by Nobel laureates 17 standout
Citing Papers
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis
2024 Standout
The therapeutic age of the neonatal Fc receptor
2023 Standout
Works of Stephan Winklmeier being referenced
Features of MOG required for recognition by patients with MOG antibody-associated disorders
2021
Identification of circulating MOG-specific B cells in patients with MOG antibodies
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Stephan Winklmeier | 55 | 99 | 87 | 13 | 194 | |
| Christoph Ruschil | 57 | 80 | 92 | 14 | 235 | |
| Gleb Makshakov | 31 | 92 | 149 | 18 | 205 | |
| Fiona Tea | 55 | 123 | 80 | 12 | 231 | |
| Ratnakar Pingili | 72 | 73 | 146 | 15 | 178 | |
| Andrew Swayne | 75 | 138 | 98 | 19 | 295 | |
| Krista D. DiSano | 118 | 76 | 169 | 19 | 275 | |
| Moli Fan | 18 | 154 | 205 | 13 | 268 | |
| Julia Mescheriakova | 27 | 104 | 208 | 12 | 267 | |
| Arlette L. Bruijstens | 26 | 183 | 152 | 12 | 258 | |
| K. Fujihara | 35 | 167 | 200 | 14 | 267 |
All Works
Login with ORCID to disown or claim papers
Loading papers...